Another quadruplet therapy for multiple myeloma: the beginning of the end for autologous haematopoietic stem-cell transplantation?
Lancet Haematol
.
2024 Jun;11(6):e392-e393.
doi: 10.1016/S2352-3026(24)00097-8.
Epub 2024 Apr 24.
Author
Natalie Scott Callander
1
Affiliation
1
Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine, Wisconsin Institutes for Medical Research, Madison, WI, USA, 53705-2275. Electronic address: nsc@medicine.wisc.edu.
PMID:
38677301
DOI:
10.1016/S2352-3026(24)00097-8
No abstract available
MeSH terms
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Hematopoietic Stem Cell Transplantation* / methods
Humans
Multiple Myeloma* / therapy
Thalidomide / therapeutic use
Transplantation, Autologous*
Substances
Thalidomide